Literature DB >> 21167219

Calmodulin regulates the non-amyloidogenic metabolism of amyloid precursor protein in platelets.

I Canobbio1, S Catricalà, C Balduini, M Torti.   

Abstract

A balance between the proteolytic processing of amyloid precursor protein APP through the amyloidogenic and the non-amyloidogenic pathways controls the production and release of amyloid β-protein, whose accumulation in the brain is associated to the onset of Alzheimer Disease. APP is also expressed on circulating platelets. The regulation of APP processing in these cells is poorly understood. In this work we show that platelets store considerable amounts of APP fragments, including sAPPα, that can be released upon stimulation of platelets. Moreover, platelet stimulation also promotes the proteolysis of intact APP expressed on the cell surface. This process is supported by an ADAM metalloproteinase, and causes the release of sAPPα. Processing of intact platelet APP is promoted also by treatment with calmodulin antagonist W7. W7-induced APP proteolysis occurs through the non-amyloidogenic pathway, is mediated by a metalloproteinase, and causes the release of sAPPα. Co-immunoprecipitation and pull-down experiments revealed a physical association between calmodulin and APP. These results document a novel role of calmodulin in the regulation of non-amyloidogenic processing of APP.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21167219     DOI: 10.1016/j.bbamcr.2010.12.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

Review 1.  Platelets and Alzheimer's disease: Potential of APP as a biomarker.

Authors:  Geneviève Evin; Qiao-Xin Li
Journal:  World J Psychiatry       Date:  2012-12-22

2.  A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3).

Authors:  Katja Möller-Hackbarth; Christin Dewitz; Olga Schweigert; Ahmad Trad; Christoph Garbers; Stefan Rose-John; Jürgen Scheller
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

Review 3.  An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels.

Authors:  Xiaoling Zhou; Yifei Li; Xiaozhe Shi; Chun Ma
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  Interaction of calmodulin with L-selectin at the membrane interface: implication on the regulation of L-selectin shedding.

Authors:  Wei Deng; Sankaranarayanan Srinivasan; Xiaofeng Zheng; John A Putkey; Renhao Li
Journal:  J Mol Biol       Date:  2011-06-02       Impact factor: 5.469

5.  Effects of ethanol on aggregation, serotonin release, and amyloid precursor protein processing in rat and human platelets.

Authors:  Daniela Ehrlich; Christian Humpel
Journal:  Platelets       Date:  2013-02-12       Impact factor: 3.862

6.  Effects of oxidative stress on amyloid precursor protein processing in rat and human platelets.

Authors:  Daniela Ehrlich; Tanja Hochstrasser; Christian Humpel
Journal:  Platelets       Date:  2012-03-02       Impact factor: 3.862

Review 7.  Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease.

Authors:  Ilaria Canobbio; Aisha Alsheikh Abubaker; Caterina Visconte; Mauro Torti; Giordano Pula
Journal:  Front Cell Neurosci       Date:  2015-03-03       Impact factor: 5.505

8.  Calmodulin Binding Proteins and Alzheimer's Disease.

Authors:  Danton H O'Day; Kristeen Eshak; Michael A Myre
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

9.  Alzheimer disease and platelets: how's that relevant.

Authors:  Silvia Catricala; Mauro Torti; Giovanni Ricevuti
Journal:  Immun Ageing       Date:  2012-09-17       Impact factor: 6.400

10.  Neuronal Ceroid Lipofuscinoses: Connecting Calcium Signalling through Calmodulin.

Authors:  Sabateeshan Mathavarajah; Danton H O'Day; Robert J Huber
Journal:  Cells       Date:  2018-10-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.